Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLG)

Last Price

1.01

Today's Change

-0.04 (3.80%)

Day's Change

1.01 - 1.16

Trading Volume

787,330

Overview

Market Cap

2 Million

Shares Outstanding

2 Million

Avg Volume

267,725

Avg Price (50 Days)

1.37

Avg Price (200 Days)

1.61

PE Ratio

-0.69

EPS

-1.46

Earnings Announcement

19-Feb-2025

Previous Close

1.05

Open

1.09

Day's Range

1.01 - 1.1599

Year Range

0.8 - 10.56

Trading Volume

786,864

Price Change Highlight

1 Day Change

-3.81%

5 Day Change

-10.62%

1 Month Change

-17.89%

3 Month Change

-53.02%

6 Month Change

-19.20%

Ytd Change

-75.60%

1 Year Change

-67.63%

3 Year Change

-99.88%

5 Year Change

-99.97%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment